An Adaptive Phase 2a/2b Study of LY3871801 in Adult Participants With Rheumatoid Arthritis
NCT05848258 · Rheumatoid Arthritis
The main purpose of this study is to evaluate the efficacy and safety of LY3871801 in adult participants with active moderately-to-severe rheumatoid arthritis (RA).
PhasePhase 2
TypeInterventional
Age18 Years
WhereHuntington Beach, California, United States + 56 more
SponsorEli Lilly and Company
▾Tap for detailsClick for full details — eligibility, all locations, contacts
57 sitesApply